The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

AbbVie also sells a continuous-delivery system for Parkinson's branded as Duopa that pumps a levodopa-carbidopa gel directly ...

Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

Although brain-implanted electrodes do help minimize the effects of Parkinson's disease and other neurological disorders, ...

Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...

BBC presenter John Stapleton has revealed he has been diagnosed with Parkinson’s disease. The 78-year-old who is best known ...

The actor and trained lifeguard played 'Newmie' on the long-running series, and appeared in 150 episodes of the show ...

The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...

In the supplementary post-hoc analysis, treatment with solengepras 150 mg group reduced OFF time by -1.78 hours (p= 0.0045) ...

The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).

Researchers at Harvard John A. Paulson School of Engineering developed a soft exoskeleton to help a person with Parkinson’s ...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).